Orvida Pharma (formerly Kamari pharma) is a clinical-stage company developing first-in-class, disease-modifying therapies for rare and underserved severe skin diseases. By targeting the TRPV3 pathway, Orvida is advancing a systemic oral treatment across multiple orphan indications, including Olmsted Syndrome, Keratodermas and Ichthyosis. With no approved disease-modifying therapies currently available for these conditions, we are committed to addressing significant unmet medical needs through a focused, efficient and mechanism-driven development strategy. Our mission is to restore skin structure and function, reduce disease burden, and reclaim quality of life.

Orvida Pharma

Org chart

Teams

Offices

Orvida Pharma

Org chart

Teams

Offices

Related companies